2021
DOI: 10.14740/jocmr4531
|View full text |Cite
|
Sign up to set email alerts
|

The Contribution of COVID-19-Forced Transformations in Critical Care Delivery to Patient Mortality: Still an Underexplored Association

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 16 publications
0
4
0
Order By: Relevance
“…During the global pandemic, as many as 67% of COVID-19 patients developed ARDS; this life-threatening complication carries a reported mortality rate of up to 40% 8,9. A 2023 study of mortality data during the first year of the COVID 19 pandemic in the United States reported an approximately 5-fold increase in deaths attributed to ARDS 10. From 2014 to 2019, ARDS-related mortality in the United States averaged 10,500 deaths per year, but this rate increased to 51,184 in 2020.…”
Section: Introductionmentioning
confidence: 99%
“…During the global pandemic, as many as 67% of COVID-19 patients developed ARDS; this life-threatening complication carries a reported mortality rate of up to 40% 8,9. A 2023 study of mortality data during the first year of the COVID 19 pandemic in the United States reported an approximately 5-fold increase in deaths attributed to ARDS 10. From 2014 to 2019, ARDS-related mortality in the United States averaged 10,500 deaths per year, but this rate increased to 51,184 in 2020.…”
Section: Introductionmentioning
confidence: 99%
“…ARDS is diagnosed in about 33% of hospitalized COVID-19 patients 1 and reported in about 10.8% of all COVID-19-related deaths. 2 Early PP has been noted to improve oxygenation and overall outcomes in patients with moderate to severe ARDS needing mechanical ventilation 3 and is associated with a lower incidence of intubation. 4,5 Complications due to prolonged PP have been reported, including endotracheal tube dislodgement, temporary desaturations, brachial plexus injuries, decubitus ulcers, ischemic optic neuropathy, and compressive neuropathies.…”
Section: Introductionmentioning
confidence: 99%
“…The most devastating of them is ARDS, with prolonged hospitalization and deaths. ARDS is diagnosed in about 33% of hospitalized COVID‐19 patients 1 and reported in about 10.8% of all COVID‐19‐related deaths 2 . Early PP has been noted to improve oxygenation and overall outcomes in patients with moderate to severe ARDS needing mechanical ventilation 3 and is associated with a lower incidence of intubation 4,5 …”
Section: Introductionmentioning
confidence: 99%
“…We do this for LNPs, since they are the leading nanoparticle format currently under development in industry, with tens of billions invested in the last few years 43,44 . We chose to target the lungs because many formulations with both affinity and physicochemical targeting have been created with the goal of ameliorating alveolar diseases, especially acute respiratory distress syndrome (ARDS), the alveolar inflammatory disease that was the primary cause of death during the COVID-19 pandemic, and still causes >75,000 deaths each year from non-COVID types of ARDS [45][46][47][48][49][50] .…”
Section: Introductionmentioning
confidence: 99%